CN102309644A - 一种治疗骨伤的中药组合物 - Google Patents
一种治疗骨伤的中药组合物 Download PDFInfo
- Publication number
- CN102309644A CN102309644A CN201110289807A CN201110289807A CN102309644A CN 102309644 A CN102309644 A CN 102309644A CN 201110289807 A CN201110289807 A CN 201110289807A CN 201110289807 A CN201110289807 A CN 201110289807A CN 102309644 A CN102309644 A CN 102309644A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- blood
- fracture
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000010392 Bone Fractures Diseases 0.000 title claims abstract description 77
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 8
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 8
- 239000004863 Frankincense Substances 0.000 claims abstract description 8
- 239000009636 Huang Qi Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims description 77
- 241000628997 Flos Species 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 12
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 241000717739 Boswellia sacra Species 0.000 claims description 7
- 241001489978 Eupolyphaga Species 0.000 claims description 7
- 241000283956 Manis Species 0.000 claims description 7
- 241001057584 Myrrha Species 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 238000007796 conventional method Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 244000080767 Areca catechu Species 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 208000006670 Multiple fractures Diseases 0.000 claims 3
- 210000004369 blood Anatomy 0.000 abstract description 64
- 239000008280 blood Substances 0.000 abstract description 64
- 230000000694 effects Effects 0.000 abstract description 40
- 208000002193 Pain Diseases 0.000 abstract description 31
- 230000036407 pain Effects 0.000 abstract description 29
- 230000001737 promoting effect Effects 0.000 abstract description 24
- 210000003205 muscle Anatomy 0.000 abstract description 20
- 210000002435 tendon Anatomy 0.000 abstract description 18
- 230000004087 circulation Effects 0.000 abstract description 6
- 230000017423 tissue regeneration Effects 0.000 abstract description 5
- 208000003044 Closed Fractures Diseases 0.000 abstract description 3
- 244000235603 Acacia catechu Species 0.000 abstract description 2
- 208000024779 Comminuted Fractures Diseases 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 244000151637 Sambucus canadensis Species 0.000 abstract 1
- 235000018735 Sambucus canadensis Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 241001300193 Speranskia Species 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 235000007123 blue elder Nutrition 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 235000007124 elderberry Nutrition 0.000 abstract 1
- 235000008995 european elder Nutrition 0.000 abstract 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052683 pyrite Inorganic materials 0.000 abstract 1
- 239000011028 pyrite Substances 0.000 abstract 1
- 206010017076 Fracture Diseases 0.000 description 55
- 238000011282 treatment Methods 0.000 description 47
- 210000000988 bone and bone Anatomy 0.000 description 24
- 230000017531 blood circulation Effects 0.000 description 23
- 208000014674 injury Diseases 0.000 description 18
- 206010042674 Swelling Diseases 0.000 description 16
- 230000008961 swelling Effects 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 13
- 230000008736 traumatic injury Effects 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 208000001132 Osteoporosis Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 238000005728 strengthening Methods 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- 230000002146 bilateral effect Effects 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 206010017081 Fracture delayed union Diseases 0.000 description 4
- 208000004044 Hypesthesia Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010062575 Muscle contracture Diseases 0.000 description 4
- 206010061363 Skeletal injury Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 208000006111 contracture Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002607 hemopoietic effect Effects 0.000 description 4
- 208000034783 hypoesthesia Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 208000026137 Soft tissue injury Diseases 0.000 description 3
- 206010047249 Venous thrombosis Diseases 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000004409 osteocyte Anatomy 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011443 conventional therapy Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000004223 radioprotective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002565 Open Fractures Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 241001050737 Sambucus williamsii Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102898078A CN102309644B (zh) | 2011-09-28 | 2011-09-28 | 一种治疗骨伤的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102898078A CN102309644B (zh) | 2011-09-28 | 2011-09-28 | 一种治疗骨伤的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102309644A true CN102309644A (zh) | 2012-01-11 |
CN102309644B CN102309644B (zh) | 2013-01-23 |
Family
ID=45423453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102898078A Active CN102309644B (zh) | 2011-09-28 | 2011-09-28 | 一种治疗骨伤的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102309644B (zh) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657824A (zh) * | 2012-05-22 | 2012-09-12 | 戴伟 | 一种治疗骨折的药物 |
CN102670856A (zh) * | 2012-05-30 | 2012-09-19 | 刘洪强 | 一种治疗骨折的药剂 |
CN102824621A (zh) * | 2012-08-27 | 2012-12-19 | 刘伟娟 | 一种治疗过度疲劳型闭合性骨折的中药洗剂制备方法 |
CN102824546A (zh) * | 2012-08-27 | 2012-12-19 | 宋敏 | 一种治疗肾阴亏虚型闭合性骨折的中药洗剂制备方法 |
CN102824538A (zh) * | 2012-08-27 | 2012-12-19 | 靳先玲 | 一种治疗胃热型闭合性骨折的中药洗剂制备方法 |
CN102824540A (zh) * | 2012-08-27 | 2012-12-19 | 马红 | 一种治疗血虚型闭合性骨折的中药洗剂制备方法 |
CN102824622A (zh) * | 2012-08-27 | 2012-12-19 | 靳先玲 | 一种治疗心悸型闭合性骨折的中药洗剂制备方法 |
CN103816350A (zh) * | 2014-03-27 | 2014-05-28 | 张华� | 促进骨折术后愈合的中药 |
CN103830471A (zh) * | 2012-11-21 | 2014-06-04 | 李玉明 | 一种用于接骨的内服中药方剂 |
CN103861047A (zh) * | 2014-04-11 | 2014-06-18 | 胡海波 | 一种治疗股骨干骨折的中药及制备方法 |
CN104666776A (zh) * | 2013-12-02 | 2015-06-03 | 青岛永通电梯工程有限公司 | 一种用于跌打损伤后的活血化瘀的中药组合物 |
CN104800804A (zh) * | 2015-04-29 | 2015-07-29 | 黄受显 | 一种快速高效治疗骨折的药物及其制备方法 |
CN105106693A (zh) * | 2015-09-02 | 2015-12-02 | 江淑芬 | 一种促进骨折愈合的中药组合物及其制备方法 |
CN105288491A (zh) * | 2015-11-30 | 2016-02-03 | 济南舜祥医药科技有限公司 | 一种治疗骨伤的软膏及制备方法 |
CN105343460A (zh) * | 2015-11-30 | 2016-02-24 | 张德东 | 一种治疗跌打损伤、骨折脱位、风湿骨病的外用中草药组合物 |
CN105362557A (zh) * | 2015-12-03 | 2016-03-02 | 乔永平 | 一种骨伤术后促愈合复方中药汤剂 |
WO2016043668A1 (en) * | 2014-09-18 | 2016-03-24 | Root King Pte Ltd | A composition suitable for vegetarians providing calcium supplementation as well as gout prevention and treatment and the method of preparation thereof |
CN105434882A (zh) * | 2015-12-31 | 2016-03-30 | 陈占文 | 一种治疗骨折中药膏剂及其制备方法 |
CN105596523A (zh) * | 2015-11-24 | 2016-05-25 | 青岛金智高新技术有限公司 | 一种用于促进股骨颈骨折愈合的中药药物 |
CN105663335A (zh) * | 2016-02-16 | 2016-06-15 | 刘勇 | 一种治疗骨伤的中药组合物及其制备方法 |
CN105878646A (zh) * | 2016-06-01 | 2016-08-24 | 曹志勇 | 一种用于治疗骨质增生,腰、颈椎椎间盘突出症的中药组合物及其制备方法 |
CN106138592A (zh) * | 2015-03-30 | 2016-11-23 | 孙林云 | 一种使中药提速的外用膏药的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586547A (zh) * | 2004-07-15 | 2005-03-02 | 李敬忍 | 一种治疗骨伤的药 |
-
2011
- 2011-09-28 CN CN2011102898078A patent/CN102309644B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586547A (zh) * | 2004-07-15 | 2005-03-02 | 李敬忍 | 一种治疗骨伤的药 |
Non-Patent Citations (1)
Title |
---|
陈朝晖等: "中药外治法治疗膝关节骨性关节炎研究进展", 《安徽中医学院学报》 * |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657824A (zh) * | 2012-05-22 | 2012-09-12 | 戴伟 | 一种治疗骨折的药物 |
CN102670856A (zh) * | 2012-05-30 | 2012-09-19 | 刘洪强 | 一种治疗骨折的药剂 |
CN102824621A (zh) * | 2012-08-27 | 2012-12-19 | 刘伟娟 | 一种治疗过度疲劳型闭合性骨折的中药洗剂制备方法 |
CN102824546A (zh) * | 2012-08-27 | 2012-12-19 | 宋敏 | 一种治疗肾阴亏虚型闭合性骨折的中药洗剂制备方法 |
CN102824538A (zh) * | 2012-08-27 | 2012-12-19 | 靳先玲 | 一种治疗胃热型闭合性骨折的中药洗剂制备方法 |
CN102824540A (zh) * | 2012-08-27 | 2012-12-19 | 马红 | 一种治疗血虚型闭合性骨折的中药洗剂制备方法 |
CN102824622A (zh) * | 2012-08-27 | 2012-12-19 | 靳先玲 | 一种治疗心悸型闭合性骨折的中药洗剂制备方法 |
CN102824621B (zh) * | 2012-08-27 | 2013-09-11 | 王秀花 | 一种治疗过度疲劳型闭合性骨折的中药洗剂制备方法 |
CN102824622B (zh) * | 2012-08-27 | 2013-10-02 | 何良爱 | 一种治疗心悸型闭合性骨折的中药洗剂制备方法 |
CN102824540B (zh) * | 2012-08-27 | 2014-03-19 | 张丽 | 一种治疗血虚型闭合性骨折的中药洗剂制备方法 |
CN102824538B (zh) * | 2012-08-27 | 2014-04-23 | 张其红 | 一种治疗胃热型闭合性骨折的中药洗剂制备方法 |
CN103830471A (zh) * | 2012-11-21 | 2014-06-04 | 李玉明 | 一种用于接骨的内服中药方剂 |
CN104666776A (zh) * | 2013-12-02 | 2015-06-03 | 青岛永通电梯工程有限公司 | 一种用于跌打损伤后的活血化瘀的中药组合物 |
CN103816350A (zh) * | 2014-03-27 | 2014-05-28 | 张华� | 促进骨折术后愈合的中药 |
CN103861047A (zh) * | 2014-04-11 | 2014-06-18 | 胡海波 | 一种治疗股骨干骨折的中药及制备方法 |
WO2016043668A1 (en) * | 2014-09-18 | 2016-03-24 | Root King Pte Ltd | A composition suitable for vegetarians providing calcium supplementation as well as gout prevention and treatment and the method of preparation thereof |
CN106138592A (zh) * | 2015-03-30 | 2016-11-23 | 孙林云 | 一种使中药提速的外用膏药的制备方法 |
CN104800804A (zh) * | 2015-04-29 | 2015-07-29 | 黄受显 | 一种快速高效治疗骨折的药物及其制备方法 |
CN105106693A (zh) * | 2015-09-02 | 2015-12-02 | 江淑芬 | 一种促进骨折愈合的中药组合物及其制备方法 |
CN105596523A (zh) * | 2015-11-24 | 2016-05-25 | 青岛金智高新技术有限公司 | 一种用于促进股骨颈骨折愈合的中药药物 |
CN105343460A (zh) * | 2015-11-30 | 2016-02-24 | 张德东 | 一种治疗跌打损伤、骨折脱位、风湿骨病的外用中草药组合物 |
CN105288491A (zh) * | 2015-11-30 | 2016-02-03 | 济南舜祥医药科技有限公司 | 一种治疗骨伤的软膏及制备方法 |
CN105362557A (zh) * | 2015-12-03 | 2016-03-02 | 乔永平 | 一种骨伤术后促愈合复方中药汤剂 |
CN105434882A (zh) * | 2015-12-31 | 2016-03-30 | 陈占文 | 一种治疗骨折中药膏剂及其制备方法 |
CN105663335A (zh) * | 2016-02-16 | 2016-06-15 | 刘勇 | 一种治疗骨伤的中药组合物及其制备方法 |
CN105878646A (zh) * | 2016-06-01 | 2016-08-24 | 曹志勇 | 一种用于治疗骨质增生,腰、颈椎椎间盘突出症的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102309644B (zh) | 2013-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102309644B (zh) | 一种治疗骨伤的中药组合物 | |
CN102327420B (zh) | 一种接骨续筋中药组合物 | |
CN101972453B (zh) | 一种治疗风湿类风湿关节炎的中药药酒及其制备方法 | |
CN102078482B (zh) | 一种治疗骨伤骨折的中药组合物及其制备方法 | |
CN102319332B (zh) | 一种麝香接骨续筋中药组合物 | |
CN104644943A (zh) | 中药组合物、含该组合物的药灸及制备方法 | |
CN104189871A (zh) | 一种治疗骨质增生的药酒 | |
CN101085327A (zh) | 一种中药透皮液 | |
CN100394955C (zh) | 一种治疗骨折、跌打损伤的中药制剂 | |
CN102895460B (zh) | 一种用于骨折、软组织损伤的中药组合物 | |
CN102247497A (zh) | 一种治疗类风湿性关节炎的中成药 | |
CN103565969A (zh) | 一种治疗软组织损伤和骨折的中药组合物 | |
CN104258304A (zh) | 一种通经祛风活络消痛的药酒 | |
CN102698085A (zh) | 治疗关节炎的中药膏药 | |
CN106075359A (zh) | 一种治疗真菌型脚气的中药组合物 | |
CN104922363A (zh) | 一种治疗骨质增生的中药组合物 | |
CN101904958B (zh) | 治疗骨折的口服药组合物 | |
CN101708292B (zh) | 一种治疗风湿、类风湿的中药 | |
CN103933285A (zh) | 一种能加快手术后骨折愈合的内服中药组方 | |
CN102406870A (zh) | 一种治疗风湿痹痛的药物 | |
CN102441131A (zh) | 一种治疗跌打损伤的中药组合物 | |
CN104524080A (zh) | 主治跌打损伤中药剂及制备方法 | |
CN104800443A (zh) | 一种补肾生髓续骨剂 | |
CN104383175A (zh) | 一种用于治疗慢性骨髓炎的药物及制备方法 | |
CN103599213A (zh) | 一种治疗骨折的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU HUAXINYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: CHAI YANFENG Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 277700 LINYI, SHANDONG PROVINCE TO: 226500 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 226500 Jiangsu city of Rugao Province Town North Street Flower Market Road No. 20 Patentee after: Jiangsu Xinyuan Pharmaceutical Co., Ltd. Address before: 277700 Department of infectious diseases, Cangshan County People's Hospital, Linyi, Shandong Patentee before: Chai Yanfeng |